Characterization of two novel SARS-CoV-2 delta variant sublineages

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant is diverse, with more than 120 sublineages within the Pango lineages. With more than 157 million doses of the anti-SARS-CoV-2 vaccine administered and approximately 124 million people fully vaccinated, Brazil is one of the most vaccinated nations globally.

Study: SARS-CoV-2 genomic monitoring in the São Paulo State unveils new sublineages of the AY.43 strain. Image Credit:  PHOTOCREO Michal Bednarek/ShutterstockStudy: SARS-CoV-2 genomic monitoring in the São Paulo State unveils new sublineages of the AY.43 strain. Image Credit: PHOTOCREO Michal Bednarek/Shutterstock

This high vaccination rate may also help in the selection of novel SARS-CoV-2 lineages and sublineages because of the accumulation of viral mutations that lead to viral fitness. Despite the preexisting gamma variant of concern (VOC) being fully replaced by the delta VOC in Brazil, no exponential growth of the new infections has been observed, probably due to the good vaccination rate.

The study

In a study published in the medRxiv* preprint server, the authors characterized the two novel AY.43 sublineages of the  SARS-CoV-2 delta variant with probable Brazilian origin. This was attributed to the observed specific clustering and specific mutation profile in the phylogenetic tree generated by Nextstrain. The raw sequence data were submitted to quality control analysis using the FastaQC software and trimmed using Trimmomatic to select the best quality sequences. The trimmed sequences were mapped against the SARS-CoV-2 reference using BWA software and samtools for reading indexing.

Pilon was used to refine the mapped files and obtain the correct indels and insertions and bcftools were used for variant calling and seqtk to assemble the consensus SARS-CoV-2 genomes. The phylogeny of the AY.43 hypothetical sublineages was reconstructed using 1,616 SARS-CoV-2 sequences generated from the Butantan Network for Pandemic Alert of SARS-CoV-2 variants.

The authors found AY.43.1 and AY.43.2 as the two novel Brazilian sublineages belonging to the AY.43 lineage. Both the novel sublineages were defined by the following characteristic nonsynonymous mutations -ORF1ab:A4133V and ORF3a:T14I for AY.43.1 and ORF1ab:G1155C for AY.43.2. The majority of the analyzed sequences of both lineages originated from the city of São Paulo.

Discussion

The study showed the crucial importance of the SARS-CoV-2 genomic surveillance to identify emerging lineages. These emerging SARS-CoV-2 lineages may significantly impact the public health systems due to increased infectivity and transmission. The T14I mutation in the ORF3a shows deleterious effects on the viral proteins. A nonsynonymous mutation in a conserved protein ORF3a, involved in viral replication and release, may affect viral functions in addition to the mutational constellation defined for the SARS-CoV-2 Delta variant.

Further studies may explore the reason for disseminating the two sublineages in São Paulo State and Brazil and their potential impact on the ongoing vaccination process. In conclusion, the molecular surveillance of the SARS-CoV-2 variants plays an important role in the rapid characterization of the virus and the accumulation of mutations that can alter the viral functions in terms of infectivity and transmissibility and help in implementing strategies to prevent their dissemination.

In conclusion, we show that SARS-CoV-2 genome monitoring is crucial for the prompt characterization of SARS-CoV-2 novel lineages and sublineages.”

*Important notice


medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:
Saurabh Chaturvedi

Written by

Saurabh Chaturvedi

Saurabh Chaturvedi is a freelance writer from Jaipur, India. He is a gold medalist in Masters in Pharmaceutical Chemistry and has extensive experience in medical writing. He is passionate about reading and enjoys watching sci-fi movies.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chaturvedi, Saurabh. (2021, December 03). Characterization of two novel SARS-CoV-2 delta variant sublineages. News-Medical. Retrieved on December 06, 2022 from https://www.news-medical.net/news/20211203/Characterization-of-two-novel-SARS-CoV-2-delta-variant-sublineages.aspx.

  • MLA

    Chaturvedi, Saurabh. "Characterization of two novel SARS-CoV-2 delta variant sublineages". News-Medical. 06 December 2022. <https://www.news-medical.net/news/20211203/Characterization-of-two-novel-SARS-CoV-2-delta-variant-sublineages.aspx>.

  • Chicago

    Chaturvedi, Saurabh. "Characterization of two novel SARS-CoV-2 delta variant sublineages". News-Medical. https://www.news-medical.net/news/20211203/Characterization-of-two-novel-SARS-CoV-2-delta-variant-sublineages.aspx. (accessed December 06, 2022).

  • Harvard

    Chaturvedi, Saurabh. 2021. Characterization of two novel SARS-CoV-2 delta variant sublineages. News-Medical, viewed 06 December 2022, https://www.news-medical.net/news/20211203/Characterization-of-two-novel-SARS-CoV-2-delta-variant-sublineages.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
Plasma from vaccinated and COVID-19 convalescent subjects as passive immunotherapy against the new Omicron BQ.1.1, XBB, and BF.7 variants